$8.30
-0.44-5.03%
À la fermeture: -
$8.30
0.000.00%
Après les heures de négociation: Oct 17, 4:00 PM EDT
Comments
Loading...
Rapport sur les intérêts à découvert
L'intérêt à découvert sur Gyre Therapeutics Inc (NASDAQ:GYRE) a augmenté lors de la dernière période de déclaration, augmentant de en hausse de 1.62M à 1.67M. Cela représente 10.98% des actions disponibles au public de l'entreprise.
L'intérêt à découvert pour Gyre Therapeutics Corp (XNAS:GYRE) a diminué au cours de la dernière période de référence, passant de 280,30 M à 275,20 M. Cela a mis 1,17 % des actions de la société disponibles au public en position courte.
Sur la base du volume moyen récent de 103.33K actions échangées par jour, il faudrait 16.17 jour(s) aux détenteurs de cet intérêt à découvert pour clôturer leurs positions sans faire monter brusquement le cours de l'action.
Intérêt à court terme
1.67M
Intérêt à court terme %
11.0%
Jours de couverture
16.17
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
GYRE | Gyre Therapeutics, Inc. Common | 09/30/2025 | 10/09/2025 | 10.98% | 15,218,298 | 1,670,982 | 103,331 | 16.17 | |
GYRE | Gyre Therapeutics, Inc. Common | 09/15/2025 | 09/24/2025 | 10.64% | 15,218,298 | 1,618,588 | 101,190 | 16 | |
GYRE | Gyre Therapeutics, Inc. Common | 08/29/2025 | 09/10/2025 | 11.43% | 15,218,298 | 1,739,858 | 93,593 | 18.59 | |
GYRE | Gyre Therapeutics, Inc. Common | 08/15/2025 | 08/26/2025 | 11.65% | 15,218,298 | 1,772,817 | 83,566 | 21.21 | |
GYRE | Gyre Therapeutics, Inc. Common | 07/31/2025 | 08/11/2025 | 12.59% | 14,714,784 | 1,852,217 | 74,675 | 24.8 | |
GYRE | Gyre Therapeutics, Inc. Common | 07/15/2025 | 07/24/2025 | 12.28% | 14,714,784 | 1,806,857 | 110,404 | 16.37 | |
GYRE | Gyre Therapeutics, Inc. Common | 06/30/2025 | 07/10/2025 | 12.26% | 14,714,784 | 1,804,234 | 253,151 | 7.13 | |
GYRE | Gyre Therapeutics, Inc. Common | 06/13/2025 | 06/25/2025 | 9.58% | 14,714,784 | 1,410,123 | 252,961 | 5.57 | |
GYRE | Gyre Therapeutics, Inc. Common | 05/30/2025 | 06/10/2025 | 9.66% | 14,714,784 | 1,421,641 | 546,003 | 2.6 | |
GYRE | Gyre Therapeutics, Inc. Common | 05/15/2025 | 05/27/2025 | 19.82% | 12,492,562 | 2,475,431 | 118,003 | 20.98 | |
GYRE | Gyre Therapeutics, Inc. Common | 04/30/2025 | 05/09/2025 | 13.46% | 17,593,457 | 2,367,978 | 96,432 | 24.56 | |
GYRE | Gyre Therapeutics, Inc. Common | 04/15/2025 | 04/25/2025 | 14.19% | 17,593,457 | 2,496,324 | 209,435 | 11.92 | |
GYRE | Gyre Therapeutics, Inc. Common | 03/31/2025 | 04/09/2025 | 16.45% | 14,513,438 | 2,387,452 | 311,939 | 7.65 | |
GYRE | Gyre Therapeutics, Inc. Common | 03/14/2025 | 03/25/2025 | 10.52% | 14,513,438 | 1,526,887 | 114,907 | 13.29 | |
GYRE | Gyre Therapeutics, Inc. Common | 02/28/2025 | 03/11/2025 | 20.02% | 6,723,268 | 1,346,149 | 59,319 | 22.69 | |
GYRE | Gyre Therapeutics, Inc. Common | 02/14/2025 | 02/26/2025 | 18.66% | 6,723,268 | 1,254,517 | 46,717 | 26.85 | |
GYRE | Gyre Therapeutics, Inc. Common | 01/31/2025 | 02/11/2025 | 18.57% | 6,723,268 | 1,248,253 | 62,409 | 20 | |
GYRE | Gyre Therapeutics, Inc. Common | 01/15/2025 | 01/27/2025 | 18.78% | 6,723,268 | 1,262,551 | 147,330 | 8.57 | |
GYRE | Gyre Therapeutics, Inc. Common | 12/31/2024 | 01/10/2025 | 14.16% | 6,723,268 | 952,311 | 118,545 | 8.03 | |
GYRE | Gyre Therapeutics, Inc. Common | 12/13/2024 | 12/24/2024 | 12.38% | 6,723,268 | 832,149 | 171,877 | 4.84 | |
GYRE | Gyre Therapeutics, Inc. Common | 11/29/2024 | 12/10/2024 | 8.17% | 6,723,268 | 549,379 | 82,102 | 6.69 | |
GYRE | Gyre Therapeutics, Inc. Common | 11/15/2024 | 11/26/2024 | 5.98% | 6,723,268 | 401,743 | 71,314 | 5.63 | |
GYRE | Gyre Therapeutics, Inc. Common | 10/31/2024 | 11/11/2024 | 2.63% | 14,325,180 | 376,581 | 29,283 | 12.86 | |
GYRE | Gyre Therapeutics, Inc. Common | 10/15/2024 | 10/24/2024 | 3.13% | 14,325,180 | 448,696 | 35,355 | 12.69 | |
GYRE | Gyre Therapeutics, Inc. Common | 09/30/2024 | 10/09/2024 | 3.19% | 14,325,180 | 457,298 | 80,808 | 5.66 | |
GYRE | Gyre Therapeutics, Inc. Common | 09/13/2024 | 09/24/2024 | 2.15% | 14,325,180 | 308,405 | 58,665 | 5.26 | |
GYRE | Gyre Therapeutics, Inc. Common | 08/30/2024 | 09/11/2024 | 2.18% | 14,325,180 | 312,978 | 45,125 | 6.94 | |
GYRE | Gyre Therapeutics, Inc. Common | 08/15/2024 | 08/26/2024 | 2.35% | 14,325,180 | 336,469 | 57,321 | 5.87 | |
GYRE | Gyre Therapeutics, Inc. Common | 07/31/2024 | 08/09/2024 | 4.98% | 6,411,112 | 319,343 | 44,794 | 7.13 | |
GYRE | Gyre Therapeutics, Inc. Common | 07/15/2024 | 07/24/2024 | 4.55% | 6,411,112 | 291,517 | 48,637 | 5.99 | |
GYRE | Gyre Therapeutics, Inc. Common | 06/28/2024 | 07/10/2024 | 2.71% | 6,411,112 | 173,599 | 149,215 | 1.16 | |
GYRE | Gyre Therapeutics, Inc. Common | 06/14/2024 | 06/26/2024 | 2.95% | 6,411,112 | 189,075 | 41,718 | 4.53 | |
GYRE | Gyre Therapeutics, Inc. Common | 05/31/2024 | 06/11/2024 | 3.17% | 6,411,112 | 203,275 | 75,395 | 2.7 | |
GYRE | Gyre Therapeutics, Inc. Common | 05/15/2024 | 05/24/2024 | 2.65% | 6,411,112 | 169,640 | 56,070 | 3.03 | |
GYRE | Gyre Therapeutics, Inc. Common | 04/30/2024 | 05/09/2024 | 1.19% | 6,411,112 | 76,070 | 64,871 | 1.17 | |
GYRE | Gyre Therapeutics, Inc. Common | 04/15/2024 | 04/24/2024 | 2.86% | 6,367,668 | 181,868 | 79,177 | 2.3 | |
GYRE | Gyre Therapeutics, Inc. Common | 03/28/2024 | 04/09/2024 | — | — | 121,193 | 52,658 | 2.3 | |
GYRE | Gyre Therapeutics, Inc. Common | 03/15/2024 | 03/26/2024 | — | — | 125,201 | 44,180 | 2.83 | |
GYRE | Gyre Therapeutics, Inc. Common | 02/29/2024 | 03/11/2024 | — | — | 139,690 | 127,932 | 1.09 | |
GYRE | Gyre Therapeutics, Inc. Common | 02/15/2024 | 02/27/2024 | — | — | 156,334 | 96,428 | 1.62 | |
GYRE | Gyre Therapeutics, Inc. Common | 01/31/2024 | 02/09/2024 | — | — | 210,013 | 94,880 | 2.21 | |
GYRE | Gyre Therapeutics, Inc. Common | 01/12/2024 | 01/24/2024 | — | — | 236,139 | 88,696 | 2.66 | |
GYRE | Gyre Therapeutics, Inc. Common | 12/29/2023 | 01/10/2024 | — | — | 305,849 | 77,576 | 3.94 | |
GYRE | Gyre Therapeutics, Inc. Common | 12/15/2023 | 12/27/2023 | — | — | 204,410 | 170,449 | 1.2 | |
GYRE | Gyre Therapeutics, Inc. Common | 11/30/2023 | 12/11/2023 | — | — | 265,535 | 204,537 | 1.3 | |
GYRE | Gyre Therapeutics, Inc. Common | 11/15/2023 | 11/27/2023 | — | — | 48,782 | 41,314 | 1.18 | |
GYRE | Gyre Therapeutics, Inc. Common | 10/31/2023 | 11/09/2023 | — | — | 81,615 | 35,133 | 2.32 |
À la recherche des actions les plus vendues à découvert?